IRENE LAKHIANI: Open Payments
NPI 1295262509 · CHERRY HILL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$256 in 14 payments from 6 companies in 2025. Trend: 2023 $16 · 2024 $435 · 2025 $256
Food & beverage: $256
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 4 | $63 |
| Alkermes, Inc. | 3 | $51 |
| Neurocrine BioSciences, Inc. | 2 | $44 |
| E.R. Squibb & Sons, L.L.C. | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
Products named: ARISTADA, INGREZZA, COBENFY, UZEDY, AUSTEDO XR, REXULTI, INVEGA SUSTENNA, ABILIFY ASIMTUFII.
Industry payments across NJ — which companies pay providers there.
